County
Cabarrus County EMS
Cabarrus County EMS (NC) carries 42 drugs across 130 dose entries in its current published protocol, effective 2026-05-26.
Drugs and doses42
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 325–1000 mg | PO | not captured | standing | page 161 |
| Fever | peds | 15 mg/kg | PO | not captured | standing | page 161 |
| Mild to moderate pain | adult | 325–1000 mg | PO | not captured | standing | page 162 |
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | page 162 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 6 mg | IV/IO | not captured | standing | pages 14, 15 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 14, 15 |
| Wide-complex tachycardia | adult | 6 mg | IV/IO | not captured | standing | pages 16, 17 |
| Wide-complex tachycardia | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 16, 17 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 2.5–5 mg | NEB | not captured | standing | pages 37, 93 |
| Anaphylaxis | peds | 2.5–5 mg | NEB | not captured | standing | pages 37, 93 |
| Asthma / bronchospasm | adult | 2.5–5 mg | NEB | not captured | standing | pages 58, 59, 64 |
| Asthma / bronchospasm | peds | 1.25–2.5 mg | NEB | not captured | standing | pages 58, 59, 64 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | page 16 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | pages 20, 21 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | pages 20, 21 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | page 10 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | pages 4, 80 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 4, 80 |
| Nerve agent exposure | adult | 2 mg | IV/IO/IM | not captured | standing | page 143 |
| Nerve agent exposure | peds | Variable | IV/IO/IM | not captured | standing | page 143 |
Buprenorphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 16 mg | SL | not captured | standing | pages 73, 74, 75 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | page 41 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 g | IV/IO | not captured | standing | page 141 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 60 mg/kg | IV/IO | not captured | standing | page 141 |
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | pages 41, 116 |
| Hyperkalemia | peds | 60 mg/kg | IV/IO | not captured | standing | pages 41, 116 |
Cefazolin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Head injury / TBI | adult | 2 g | IV/IO | not captured | standing | page 119 |
| Head injury / TBI | peds | 30 mg/kg | IV/IO | not captured | standing | page 119 |
| Trauma / hemorrhage | adult | 2 g | IV/IO | not captured | standing | page 118 |
| Trauma / hemorrhage | peds | 30 mg/kg | IV/IO | not captured | standing | page 118 |
Clonidine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.1 mg | PO | not captured | standing | pages 73, 74, 75 |
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 10 mg | IV/IO/IM | not captured | standing | pages 45, 98 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 1 mL/kg | IV/IO | not captured | standing | pages 39, 48, 49, 95 |
| Hypoglycemia | peds | 2 mL/kg | IV/IO | not captured | standing | pages 39, 48, 49, 95 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 0.25 mg/kg | IV/IO | not captured | standing | page 14 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 25–50 mg | PO | not captured | standing | pages 37, 93 |
| Anaphylaxis | adult | 25–50 mg | IV/IO/IM | not captured | standing | pages 37, 93 |
| Anaphylaxis | peds | 1 mg/kg | PO | not captured | standing | pages 37, 93 |
| Anaphylaxis | peds | 1 mg/kg | IV/IO/IM | not captured | standing | pages 37, 93 |
| Dystonic reaction | adult | 50 mg | IV/IO/IM/PO | not captured | standing | page 176 |
| Dystonic reaction | peds | 1 mg/kg | IV/IO/IM/PO | not captured | standing | page 176 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | pages 37, 93 |
| Anaphylaxis | peds | < 30 kg 0.15 mg; >= 30 kg 0.3 - 0.5 mg | IM | not captured | standing | pages 37, 93 |
| Bradycardia | adult | 6–8 mcg | IV/IO | not captured | standing | pages 4, 80 |
| Bradycardia | peds | 10 mcg | IV/IO | not captured | standing | pages 4, 80 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 2, 3, 20, 21, 78, 79, 89, 90 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 2, 3, 20, 21, 78, 79, 89, 90 |
| Croup | peds | 1 mg | NEB | not captured | standing | pages 58, 64 |
| Hypotension / shock | adult | 6–8 mcg | IV/IO | not captured | standing | pages 44, 97 |
| Hypotension / shock | peds | 10 mcg | IV/IO | not captured | standing | pages 44, 97 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 56 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 1 mcg/kg | IV/IO/IM | not captured | standing | page 10 |
| ACS / chest pain | adult | 2 mcg/kg | IN | not captured | standing | page 10 |
| Mild to moderate pain | adult | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 163 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 163 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 40 mg | IV | not captured | standing | page 12 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1–2 mg | IV/IO/IM | not captured | standing | page 141 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 141 |
| Hypoglycemia | adult | 1–2 mg | IM | not captured | standing | pages 39, 95 |
| Hypoglycemia | peds | 0.1 mg/kg | IM | not captured | standing | pages 39, 95 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 70 mg/kg | IV/IO | not captured | standing | page 132 |
| Cyanide poisoning | peds | 70 mg/kg | IV/IO | not captured | standing | page 132 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 400–600 mg | PO | not captured | standing | page 161 |
| Fever | peds | 10 mg/kg | PO | not captured | standing | page 161 |
| Mild to moderate pain | adult | 400–600 mg | PO | not captured | standing | page 162 |
| Mild to moderate pain | peds | 10 mg/kg | PO | not captured | standing | page 162 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.5 mg | NEB | not captured | standing | pages 37, 93 |
| Anaphylaxis | peds | 0.5 mg | NEB | not captured | standing | pages 37, 93 |
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | pages 58, 59, 64 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | pages 58, 59, 64 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperactive delirium | adult | 4 mg/kg | IM | not captured | standing | page 179 |
| RSI induction | adult | 2 mg/kg | IV/IO | not captured | standing | page 56 |
| RSI induction | adult | 2 mg/kg | IV/IO | not captured | standing | page 66 |
| RSI induction | adult | 4 mg/kg | IM | not captured | standing | page 56 |
| RSI induction | peds | 2 mg/kg | IM | not captured | standing | page 56 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15 mg | IV/IO | not captured | standing | page 162 |
| Mild to moderate pain | adult | 30 mg | IM | not captured | standing | page 162 |
| Mild to moderate pain | peds | 0.5 mg/kg | IV/IO | not captured | standing | page 162 |
| Mild to moderate pain | peds | 0.5 mg/kg | IM | not captured | standing | page 162 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg | IV/IO | not captured | standing | page 50 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 20 mg | IO | not captured | standing | page 155 |
| Other | peds | 0.5 mg/kg | IO | not captured | standing | page 155 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV/IO | not captured | standing | pages 58, 59 |
| Eclampsia / pre-eclampsia | adult | 4 g | IV/IO | not captured | standing | page 50 |
| Other | peds | 40 mg/kg | IV/IO | not captured | standing | page 64 |
| Wide-complex tachycardia | adult | 2 g | IV/IO | not captured | standing | page 18 |
| VF / pulseless VT | adult | 2 g | IV/IO | not captured | standing | page 20 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 125 mg | IV/IO | not captured | standing | pages 37, 93 |
| Anaphylaxis | peds | 2 mg/kg | IV/IO | not captured | standing | pages 37, 93 |
| Asthma / bronchospasm | adult | 125 mg | IV/IO/IM | not captured | standing | pages 58, 59 |
| Asthma / bronchospasm | peds | 2 mg/kg | IV/IO/IM | not captured | standing | pages 58, 59 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2 mg | IV/IO/IM/IN | not captured | standing | page 12 |
| Agitation | adult | 2 mg | IV/IO/IN | not captured | standing | page 178 |
| Agitation | adult | 2 mg | IM | not captured | standing | page 178 |
| Agitation | peds | 0.1–0.2 mg/kg | IV/IO/IN | not captured | standing | page 178 |
| Agitation | peds | 0.1–0.2 mg/kg | IM | not captured | standing | page 178 |
| Hyperactive delirium | adult | 5 mg | IM | not captured | standing | page 179 |
| Hyperactive delirium | peds | 0.1–0.2 mg/kg | IM | not captured | standing | page 179 |
| Procedural sedation | adult | 2 mg | IV/IO/IM/IN | not captured | standing | page 4 |
| Procedural sedation | adult | 2 mg | IV/IO/IN | not captured | standing | pages 14, 16, 18, 85, 87 |
| Seizure | adult | 10 mg | IM | not captured | standing | page 167 |
| Seizure | adult | 2 mg | IV/IO | not captured | standing | page 167 |
| Seizure | peds | 0.2 mg/kg | IV/IO | not captured | standing | page 167 |
| Seizure | peds | 0.2 mg/kg | IM | not captured | standing | page 167 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 163 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 163 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4–2 mg | IM/IN | not captured | standing | pages 6, 83 |
| Opioid overdose | adult | 0.4–2 mg | IV/IO | not captured | standing | pages 6, 83 |
| Opioid overdose | peds | 0.1 mg/kg | IM/IN | not captured | standing | pages 6, 83 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 6, 83 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.3–0.4 mg | SL | not captured | standing | page 10 |
| CHF / pulmonary edema | adult | 0.3–0.4 mg | SL | not captured | standing | page 12 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 4 mg | PO | not captured | standing | pages 73, 74 |
| Other | adult | 4 mg | IV/IO/IM/PO/ODT | not captured | standing | page 149 |
| Other | peds | 0.15 mg/kg | IV/IO/IM/PO/ODT | not captured | standing | page 149 |
Oxymetazoline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 spray | IN | not captured | standing | page 159 |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 unit | IM | not captured | standing | pages 46, 47, 50, 51 |
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 600 mg | IV/IO/IM | not captured | standing | page 143 |
| Nerve agent exposure | peds | 15–25 mg/kg | IV/IO/IM | not captured | standing | page 143 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 12.5 mg | IV/IO/IM | not captured | standing | page 149 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 100 mEq | IV/IO | not captured | standing | pages 41, 116 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 41, 116 |
| Tricyclic overdose | adult | 100 mEq | IV/IO | not captured | standing | page 141 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | page 141 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 2 mg/kg | IV/IO | not captured | standing | page 56 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 2 g | IV/IO | not captured | standing | pages 50, 51, 121, 122 |
| Trauma / hemorrhage | adult | 500 mg | TOP | not captured | standing | page 157 |
| Trauma / hemorrhage | peds | 1 g | IV/IO | not captured | standing | pages 50, 51, 121, 122 |
Vecuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg | IV/IO | not captured | standing | page 66 |
| RSI induction | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 56 |